
Hematology-Oncologycase reportgene therapy
Cases of High-Titer Inhibitor Formation After AAV Gene Therapy for Hemophilia A
By MedXY|Oct 20, 2026
Two hemophilia A patients developed persistent high-titer FVIII inhibitors following AAV-mediated gene therapy with a bioengineered FVIII transgene despite prior extensive FVIII exposure.